Heart Medication Under Scrutiny: A Growing Trend of Drug Re-Evaluations
A widely prescribed heart medication, nicorandil, is facing renewed scrutiny, prompting calls for its removal from the market. The prestigious medical review Prescrire has directly appealed to French health authorities, citing concerns that the drug is “more dangerous than useful.” This situation isn’t isolated. it reflects a broader trend of increased vigilance and re-evaluation of established pharmaceuticals.
Millions Affected: The Scale of Nicorandil Use
Nicorandil is used to treat angina, chest pain caused by reduced blood flow to the heart. Approximately 71,000 French patients received nearly one million reimbursed boxes of the medication in 2024. Despite repeated warnings from the French National Agency for the Safety of Medicines and Medical Devices (ANSM) regarding its side effects, it remains covered by the national healthcare system at 65%.
Severe Ulcerations: The Core Safety Concern
The primary danger associated with nicorandil lies in its potential to cause severe skin and digestive ulcerations. These lesions can lead to serious complications, including digestive perforations, fistulas, abscesses and gastrointestinal hemorrhages. Between 2017 and 2024, 62 cases of nicorandil-related ulcerations were officially reported, but Prescrire suggests this number significantly underestimates the true extent of the problem due to underreporting.
Recognizing the Warning Signs
Individuals taking nicorandil should be vigilant for symptoms such as persistent abdominal pain, mouth ulcers that don’t heal, suspicious skin lesions, bleeding from the digestive tract, or pain when swallowing. The ANSM emphasizes the “imperative necessity” of immediately stopping the medication and seeking urgent medical attention if any of these symptoms appear.
A Growing “Blacklist” of Questionable Medications
Nicorandil is now part of a growing list of drugs that Prescrire recommends avoiding. This annual “blacklist” identifies medications where the risks outweigh the benefits, based on rigorous scientific analysis and consideration of available alternatives. Other cardiovascular drugs are as well appearing on this list, indicating heightened scrutiny within this therapeutic area.
Why the Delay in Action?
A key question is why, despite known risks, nicorandil remains authorized and reimbursed. Prescrire points to the inertia of health authorities. The French High Authority for Health (HAS) maintained a favorable opinion on the drug’s coverage in 2015, and no re-evaluation has occurred since, despite accumulating reports of adverse effects.
Are Alternatives Available?
Fortunately, several alternative treatments exist for angina. First-line medications like beta-blockers, calcium channel blockers, and nitrates generally offer effective relief with a more established safety profile. Nicorandil is typically reserved for cases where these initial treatments fail or are contraindicated. However, even in complex situations, alternative strategies – optimizing dosages, combining medications, or exploring non-pharmacological approaches – may be viable.
What Should Patients Do?
If you are currently taking nicorandil, it’s crucial to discuss your concerns with your cardiologist. Do not stop taking the medication abruptly without medical advice. Schedule an appointment to review the risks and benefits in your specific case and explore potential alternatives. Be vigilant for any warning signs and seek immediate medical attention if they arise.
Pro Tip: Keep a detailed record of any medications you are taking, including dosages and any side effects you experience. Share this information with your doctor during appointments.
The Broader Trend: Increased Pharmaceutical Scrutiny
The case of nicorandil highlights a growing trend toward increased scrutiny of pharmaceutical safety. The delay between identifying a risk and taking concrete action is a recurring issue. This underscores the need for more robust pharmacovigilance systems and a willingness to re-evaluate established treatments in light of new evidence.
Did you know? Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem.
FAQ
- What is nicorandil used for? Nicorandil is used to treat angina, chest pain caused by reduced blood flow to the heart.
- What are the main risks associated with nicorandil? The primary risk is the development of severe skin and digestive ulcerations.
- Should I stop taking nicorandil immediately? No. Do not stop taking the medication without consulting your doctor.
- Are there alternatives to nicorandil? Yes, several other medications are available to treat angina.
- Where can I uncover more information about drug safety? Consult your doctor or visit the website of your national health authority.
This situation emphasizes the importance of proactive communication between patients and healthcare providers. Staying informed and actively participating in your healthcare decisions is essential for ensuring the safest and most effective treatment possible.
Worth a look